In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
- TRADE NAME: Sectral (Sanofi-Aventis)
- INDICATIONS: Hypertension, angina, ventricular arrhythmias
- CLASS: Antiarrhythmic class II, Beta adrenergic blocker, Beta blocker
- HALF-LIFE: 3–7 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Adrenergic neurone blockers, Alcohol, Aldesleukin, Alpha blockers, Alprostadil, Amiodarone, Angiotensin II receptor antagonists, Antiarrhythmics, Antidiabetics, Anxiolytics and hypnotics, Baclofen, Calcium channel blockers, Cardiac glycosides, Clonidine, Corticosteroids, Diazoxide, Diltiazem, Disopyramide, Diuretics, Ergotamine, Estrogens, Flecainide, General anesthetics, Hydralazine, Insulin, Levodopa, MAO inhibitors, Mefloquine, Methyldopa, Methysergide, Minoxidil, Moxisylyte, Moxonidine, Nifedipine, Nitrates, Nitroprusside, NSAIDs, Phenothiazines, Pilocarpine, Prazosin, Tizanidine, Verapamil
- See adverse reactions attributed to class:
Contraindicated in persistently severe bradycardia, second- and third-degree heart
block, overt cardiac failure, and cardiogenic shock.
Cutaneous side effects of beta-receptor blockers are clinically polymorphous. They apparently appear after several months of continuous therapy.
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
